Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Submit for the Fierce Pharma Marketing Awards - Deadline ends this Friday, July 3rd
Xtandi
Pharma
Inside Astellas CEO's plan to counter Xtandi's patent cliff
“It is not simply the cost optimization, but the way we do our business,” Astellas CEO Naoki Okamura explained to Fierce.
Angus Liu
Jun 11, 2026 6:00pm
ASCO: Pfizer one-ups J&J in prostate cancer
May 30, 2026 8:00am
Fierce Biotech
Astellas targets more deals, cost cutting to swerve patent cliff
May 26, 2026 7:35am
Sun-Organon, Astellas, BeOne—Fierce Pharma Asia
May 1, 2026 8:43am
Astellas projects Xtandi decline but overall growth in FY2026
Apr 27, 2026 11:30am
Pfizer eyes earlier Talzenna use after ph. 3 prostate cancer win
Mar 19, 2026 6:45am
